BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 25, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Prolacria diquafosol tetrasodium: Phase III data

Top-line data from a North American Phase III (Trial 03-113) trial in 490 patients with a fluorescein staining score of 3 at baseline showed that Prolacria given 4 times daily missed the primary endpoint of a significantly greater proportion of patients that...

Read the full 190 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >